FDA Approves Lilly Drug to Treat ADHD
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
FDA Approves Lilly Drug to Treat ADHD
8 May 08, 14:01
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says the Food and Drug Administration has approved Strattera to treat Attention-Deficit/Hyperactivity ...
more

 

 
© 2007 nafdacnigeria.org